Background: Despite efforts to improve access to Medications for Opioid Use Disorder
(MOUD), such as buprenorphine, the number of opioid overdoses in the United States …

Abstract Background Primary care providers (PCPs) are essential to increasing access to
office-based buprenorphine medication treatment for opioid use disorder (B-MOUD) …

Abstract Background and Objectives Strong evidence supports efficacy of medications for
opioid use disorder (MOUD), but stringent prescribing policies impair access. Many …

Background: In the US, seventy percent of drug-related deaths are attributed to opioids. In
response to the ongoing opioid crisis, New Jersey's (NJ) Medicaid program implemented the …

Background Until the end of 2022, a special registration, known as the X-waiver, was
required to prescribe buprenorphine in the US. Before its removal, US federal regulations …

Background The opioid epidemic is a major health challenge in the United States. Purpose
Members from the American Academy of Nursing joined to write a consensus paper about …

Opioid use disorder (OUD) is a major public health concern in the United States. The opioid
crisis has taken hundreds of thousands of lives in the past 20 years, and it is predicted to …

Background: Treating opioid use disorder (OUD) with buprenorphine or methadone
significantly reduces overdose and all-cause mortality. Prior studies demonstrate that …

Objectives The aims of the study are to evaluate community pharmacists' knowledge and
perceptions regarding buprenorphine for opioid use disorder and their willingness to …

Introduction: This brief report describes how a family medicine residency practice (FMRP)
leveraged a resident-led quality improvement project and a grant-funded Addiction …